Current Immune-Related Molecular Approach in Combating Nasopharyngeal Cancer

Soehartati  Argadikoesoema; Marlinda Adham; Henry Kodrat; Demak Lumban Tobing; I. Made Haryoga; Agustinus Gatot Dwiyono; Yoseph Adi Kristian

doi:10.14740/wjon1214

Current Immune-Related Molecular Approach in Combating Nasopharyngeal Cancer

Soehartati Argadikoesoema, Marlinda Adham, Henry Kodrat, Demak Lumban Tobing, I. Made Haryoga, Agustinus Gatot Dwiyono, Yoseph Adi Kristian

Research output: Contribution to journal › Article

Abstract

Nasopharyngeal cancer is a cancer closely related to Epstein-Barr virus (EBV) infection. EBV protein has been shown to be related to various oncogenic development. Suppression of tumor suppressor genes, upregulating molecules to prevent immune attack, downregulating pro-apoptotic proteins, and stimulating local immune suppressive environment are among some roles that EBV proteins can exert on host cells. All those factors combined together with underlying genetic susceptibility of host cells further increase the chance of nasopharyngeal cancer development. Approach targeting those carcinogenesis pathways has been tested with marginal benefit. A newer approach boosting immune cells to increase recognition of tumor antigen and promoting cytotoxic T cell attack has shown promising clinical benefit. Further combination of those immunotherapies with other modality, in particular radiotherapy, has resulted in amplification of cancer killing.

Original language	English
Pages (from-to)	157-161
Journal	World Journal of Oncology
Volume	10
Issue number	4-5
DOIs	https://doi.org/10.14740/wjon1214
Publication status	Published - 1 Jan 2019

Access to Document

10.14740/wjon1214

World Journal of Oncology

Fingerprint Dive into the research topics of 'Current Immune-Related Molecular Approach in Combating Nasopharyngeal Cancer'. Together they form a unique fingerprint.

Cite this

Argadikoesoema, S., Adham, M., Kodrat, H., Tobing, D. L., Haryoga, I. M., Dwiyono, A. G., & Kristian, Y. A. (2019). Current Immune-Related Molecular Approach in Combating Nasopharyngeal Cancer. World Journal of Oncology, 10(4-5), 157-161. https://doi.org/10.14740/wjon1214

@article{5af0f8d3b84f4092b56e8a017e42a5ed,

title = "Current Immune-Related Molecular Approach in Combating Nasopharyngeal Cancer",

abstract = "Nasopharyngeal cancer is a cancer closely related to Epstein-Barr virus (EBV) infection. EBV protein has been shown to be related to various oncogenic development. Suppression of tumor suppressor genes, upregulating molecules to prevent immune attack, downregulating pro-apoptotic proteins, and stimulating local immune suppressive environment are among some roles that EBV proteins can exert on host cells. All those factors combined together with underlying genetic susceptibility of host cells further increase the chance of nasopharyngeal cancer development. Approach targeting those carcinogenesis pathways has been tested with marginal benefit. A newer approach boosting immune cells to increase recognition of tumor antigen and promoting cytotoxic T cell attack has shown promising clinical benefit. Further combination of those immunotherapies with other modality, in particular radiotherapy, has resulted in amplification of cancer killing.",

author = "Soehartati Argadikoesoema and Marlinda Adham and Henry Kodrat and Tobing, {Demak Lumban} and Haryoga, {I. Made} and Dwiyono, {Agustinus Gatot} and Kristian, {Yoseph Adi}",

year = "2019",

month = jan,

day = "1",

doi = "10.14740/wjon1214",

language = "English",

volume = "10",

pages = "157--161",

journal = "World Journal of Oncology",

issn = "1920-4531",

publisher = "Elmer Press Inc",

number = "4-5",

}

TY - JOUR

T1 - Current Immune-Related Molecular Approach in Combating Nasopharyngeal Cancer

AU - Argadikoesoema, Soehartati

AU - Adham, Marlinda

AU - Kodrat, Henry

AU - Tobing, Demak Lumban

AU - Haryoga, I. Made

AU - Dwiyono, Agustinus Gatot

AU - Kristian, Yoseph Adi

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Nasopharyngeal cancer is a cancer closely related to Epstein-Barr virus (EBV) infection. EBV protein has been shown to be related to various oncogenic development. Suppression of tumor suppressor genes, upregulating molecules to prevent immune attack, downregulating pro-apoptotic proteins, and stimulating local immune suppressive environment are among some roles that EBV proteins can exert on host cells. All those factors combined together with underlying genetic susceptibility of host cells further increase the chance of nasopharyngeal cancer development. Approach targeting those carcinogenesis pathways has been tested with marginal benefit. A newer approach boosting immune cells to increase recognition of tumor antigen and promoting cytotoxic T cell attack has shown promising clinical benefit. Further combination of those immunotherapies with other modality, in particular radiotherapy, has resulted in amplification of cancer killing.

AB - Nasopharyngeal cancer is a cancer closely related to Epstein-Barr virus (EBV) infection. EBV protein has been shown to be related to various oncogenic development. Suppression of tumor suppressor genes, upregulating molecules to prevent immune attack, downregulating pro-apoptotic proteins, and stimulating local immune suppressive environment are among some roles that EBV proteins can exert on host cells. All those factors combined together with underlying genetic susceptibility of host cells further increase the chance of nasopharyngeal cancer development. Approach targeting those carcinogenesis pathways has been tested with marginal benefit. A newer approach boosting immune cells to increase recognition of tumor antigen and promoting cytotoxic T cell attack has shown promising clinical benefit. Further combination of those immunotherapies with other modality, in particular radiotherapy, has resulted in amplification of cancer killing.

UR - https://www.wjon.org/index.php/WJON/article/view/1214

U2 - 10.14740/wjon1214

DO - 10.14740/wjon1214

M3 - Article

VL - 10

SP - 157

EP - 161

JO - World Journal of Oncology

JF - World Journal of Oncology

SN - 1920-4531

IS - 4-5

ER -